
Overview
Dr. Sarah Yentz received her medical degree from the University of Michigan and completed Internal Medicine residency training at Northwestern Memorial Hospital where she served as chief resident 2014-2015. She completed her fellowship in Hematology/Oncology at the University of Michigan in 2018.
Dr. Yentz is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, and Chromophobe Renal Cell Carcinoma.
She is actively involved in clinical research, co-authoring 25 peer reviewed articles. Dr. Yentz is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
7500 Challis Rd, Entrance1, Level 1, Brighton, MI 48116
1500 E Medical Center Dr, Floor 1, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Yentz has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Rogel Cancer Center
Scott Schuetze is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Schuetze is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma. Dr. Schuetze is currently accepting new patients.
Rogel Cancer Center
Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology. Dr. Vaishampayan is currently accepting new patients.
Frequently Asked Questions about Dr. Sarah E. Yentz
How do I make an appointment with Dr. Sarah E. Yentz?
You can book an appointment with Dr. Sarah E. Yentz by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Sarah E. Yentz a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sarah E. Yentz is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Sarah E. Yentz specialize in?
While Dr. Sarah E. Yentz is a Oncology, they have specific expertise in Prostate Cancer, Renal Cell Carcinoma (RCC), and Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Sarah E. Yentz participate in research or clinical trials?
Yes. Dr. Sarah E. Yentz has published 25 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Sarah E. Yentz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Sarah E. Yentz accept my insurance?
Dr. Sarah E. Yentz accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Prostate CancerDr. Yentz isDistinguished. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Yentz isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Advanced
- Adult Soft Tissue SarcomaDr. Yentz isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Yentz isAdvanced. Learn about Bladder Cancer.
- Chromophobe Renal Cell Carcinoma
- Clear Cell SarcomaDr. Yentz isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Yentz isAdvanced. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Yentz isAdvanced. Learn about Familial Wilms Tumor 2.
- MelanomaDr. Yentz isAdvanced. Learn about Melanoma.
- Melanoma of the EyeDr. Yentz isAdvanced. Learn about Melanoma of the Eye.
- Metastatic Uveal MelanomaDr. Yentz isAdvanced. Learn about Metastatic Uveal Melanoma.
- Muscle Invasive Bladder CancerDr. Yentz isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder Cancer
- Urothelial CancerDr. Yentz isAdvanced. Learn about Urothelial Cancer.
- Wilms TumorDr. Yentz isAdvanced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor Syndromes
- Experienced
- Adrenal Insufficiency PediatricDr. Yentz isExperienced. Learn about Adrenal Insufficiency Pediatric.
- Breast Cancer in MenDr. Yentz isExperienced. Learn about Breast Cancer in Men.
- Lymphofollicular HyperplasiaDr. Yentz isExperienced. Learn about Lymphofollicular Hyperplasia.
- Merkel Cell CarcinomaDr. Yentz isExperienced. Learn about Merkel Cell Carcinoma.
- Metastatic Brain TumorDr. Yentz isExperienced. Learn about Metastatic Brain Tumor.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Yentz isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Posterior Fossa TumorDr. Yentz isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Secondary Adrenal InsufficiencyDr. Yentz isExperienced. Learn about Secondary Adrenal Insufficiency.
- Upper Tract Urothelial Carcinoma (UTUC)


